Warning letter
Northeast Georgia Medical Center Inc.: warning letter of Apr 25, 2000
FDA warning letter UCM068373 · Center for Biologics Evaluation and Research
Key facts
| Reference number | UCM068373 |
|---|---|
| Company | Northeast Georgia Medical Center Inc. |
| Subject | IRB (Institutional Review Board) |
| Issue date | Apr 25, 2000 |
| Posted date | Apr 25, 2000 |
| Issuing office | Center for Biologics Evaluation and Research |
| Product type | Devices |
| CFR sections cited | 56.108(a), 50.25, 56.120, 50, 56.107(d), 56.109(f), 56.115(a)(1), 56.115(a)(2), 56.108(c), 56.109(e) |
| Country | 3 |
| Inspection city | Gainesville |
| Inspection ZIP | 30501-3715 |
| Inspection start date | Feb 22, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: